Novo Nordisk's '2-in-3 Indians Have Fatty Liver' Claim Needs Hard Scrutiny

Mainstream NAFLD estimates for India's general population run 9–32%; a 67% figure almost certainly reflects a high-risk subgroup or unverified internal data, not national prevalence—and Novo Nordisk has skin in the MASH game.

bt-corporate · 7/17/2026, 12:01:58 PM · Ask about this →